{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:35:26Z","timestamp":1747204526896,"version":"3.40.5"},"posted":{"date-parts":[[2023,6,7]]},"group-title":"In Review","reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,2,3]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background<\/bold>\nWith the opioid crisis, surging methamphetamine use, and healthcare disruptions due to SARS-CoV-2, serious injection related infections (SIRIs), like endocarditis, have increased significantly. Hospitalizations for SIRI provide a unique opportunity for persons who inject drugs (PWID) to engage in addiction treatment and infection prevention, yet many providers miss opportunities for evidence-based care due to busy inpatient services and lack of awareness. To improve hospital care, we developed a 5-item SIRI Checklist for providers as a standardized reminder to offer medication for opioid use disorder (MOUD), HIV and HCV screening, harm reduction counseling, and referral to community-based care. We also formalized an Intensive Peer Recovery Coach protocol to support PWID on discharge. We hypothesized that the SIRI Checklist and Intensive Peer Intervention would increase use of hospital-based services (HIV, HCV screening, MOUD) and linkage to community-based care: PrEP prescription, MOUD prescription, and related outpatient visit(s).\nMethods\nThis is a feasibility study and randomized control trial of a checklist and intensive peer intervention for hospitalized PWID with SIRI admitted to UAB Hospital. We will recruit 60 PWID who will be randomized to one of 4 groups (SIRI Checklist, SIRI Checklist + Enhanced Peer, Enhanced Peer, and Standard of Care). Results will be analyzed using a 2x2 factorial design. We will use surveys to collect data on drug use behaviors, stigma, HIV risk, and PrEP interest and awareness. Our primary outcome of feasibility will include the ability to recruit hospitalized PWID and retain them in the study to determine post-discharge clinical outcomes. Additionally, we will explore clinical outcomes using a combination of patient surveys and electronic medical record data (HIV, HCV testing, MOUD and PrEP prescriptions).\nThis study is approved by UAB IRB #300009134.\n<bold>Discussion<\/bold>\nThis feasibility study is a necessary step in designing and testing patient-centered interventions to improve public health for rural and Southern PWID. By testing low barrier interventions that are accessible and reproducible in states without access to Medicaid expansion and robust public health infrastructure, we aim to identify models of care that promote linkage and engagement in community care.\n<bold>Trial Registration<\/bold>: NCT05480956<\/p>","DOI":"10.21203\/rs.3.rs-2546488\/v1","type":"posted-content","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T18:19:59Z","timestamp":1686161999000},"source":"Crossref","is-referenced-by-count":1,"title":["A Study Protocol to Increase Engagement in Evidence Based Hospital and Community Based Care Using a Serious Injection Related Infections (SIRI) Checklist and Enhanced Peer for Hospitalized PWID (ShaPe)"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-9385","authenticated-orcid":false,"given":"Margaret","family":"Baldwin","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Jeziorski","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel","family":"Parman","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Gagnon","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Alana","family":"Nichols","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davis","family":"Bradford","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, General Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylee","family":"Crockett","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, Family & Community Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Eaton","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Heersink School of Medicine, Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","volume-title":"Bailey, and Lauren O'Malley. Opioid-Related Inpatient Stays and Emergency Department Visits by State, 2009\u20132014","author":"Audrey J","year":"2016","unstructured":"Audrey J, Weiss AE, Marguerite L, Barrett CA, Steiner MK. Bailey, and Lauren O'Malley. Opioid-Related Inpatient Stays and Emergency Department Visits by State, 2009\u20132014. Contract No.: HCUP Statistical Brief #219: Agency for Healthcare Research and Quality; 2016."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Wurcel AG, Anderson JE, Chui KK, Skinner S, Knox TA, Snydman DR, et al. editors. Increasing infectious endocarditis admissions among young people who inject drugs. Open forum infectious diseases; 2016: Oxford University Press.","DOI":"10.1093\/ofid\/ofw157"},{"year":"2022","author":"Bradley H","key":"ref3","unstructured":"Bradley H, Hall E, Asher A, Furukawa N, Jones CM, Shealey J et al. Estimated number of people who inject drugs in the United States.Clinical Infectious Diseases. 2022."},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/cid\/ciy722","article-title":"A 9-point risk assessment for patients who inject drugs and require intravenous antibiotics: focusing inpatient resources on patients at greatest risk of ongoing drug use","volume":"68","author":"Eaton EF","year":"2019","unstructured":"Eaton EF, Mathews RE, Lane PS, Paddock CS, Rodriguez JM, Taylor BB, et al. A 9-point risk assessment for patients who inject drugs and require intravenous antibiotics: focusing inpatient resources on patients at greatest risk of ongoing drug use. Clin Infect Dis. 2019;68(6):1041\u20133.","journal-title":"Clin Infect Dis"},{"issue":"Supplement5","key":"ref5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/infdis\/jiaa129","article-title":"Not just endocarditis: hospitalizations for selected invasive infections among persons with opioid and stimulant use diagnoses\u2014North Carolina, 2010\u20132018","volume":"222","author":"Sredl M","year":"2020","unstructured":"Sredl M, Fleischauer AT, Moore Z, Rosen DL, Schranz AJ. Not just endocarditis: hospitalizations for selected invasive infections among persons with opioid and stimulant use diagnoses\u2014North Carolina, 2010\u20132018. J Infect Dis. 2020;222(Supplement5):458\u2013S64.","journal-title":"J Infect Dis"},{"volume-title":"In-hospital illicit drug use and patient-directed discharge: barriers to care for patients with injection-related infections. Open forum infectious diseases","year":"2020","key":"ref6","unstructured":"Eaton EF, Westfall AO, McClesky B, Paddock CS, Lane PS, Cropsey KL, et al. editors. In-hospital illicit drug use and patient-directed discharge: barriers to care for patients with injection-related infections. Open forum infectious diseases. Oxford University Press US; 2020."},{"issue":"Supplement5","key":"ref7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/infdis\/jiaa005","article-title":"An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges Remain","volume":"222","author":"Eaton EF","year":"2020","unstructured":"Eaton EF, Lee RA, Westfall AO, Mathews RE, McCleskey B, Paddock CS, et al. An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges Remain. J Infect Dis. 2020;222(Supplement5):499\u2013S505.","journal-title":"J Infect Dis"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ADM.0000000000000496","article-title":"The role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service","volume":"13","author":"Priest KC","year":"2019","unstructured":"Priest KC, McCarty D. The role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service. J Addict Med. 2019;13(2):104.","journal-title":"J Addict Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2018.06.011","article-title":"In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs","volume":"92","author":"Fanucchi LC","year":"2018","unstructured":"Fanucchi LC, Lofwall MR, Nuzzo PA, Walsh SL. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs. J Subst Abuse Treat. 2018;92:64\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks LR","year":"2019","unstructured":"Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2019;68(11):1935\u20137.","journal-title":"Clin Infect Dis"},{"year":"2022","author":"Englander H","key":"ref11","unstructured":"Englander H, Jones A, Krawczyk N, Patten A, Roberts T, Korthuis PT et al. A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews.Journal of General Internal Medicine. 2022."},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13054-015-0938-1","article-title":"A comprehensive method to develop a checklist to increase safety of intra-hospital transport of critically ill patients","volume":"19","author":"Brunsveld-Reinders AH","year":"2015","unstructured":"Brunsveld-Reinders AH, Arbous MS, Kuiper SG, de Jonge E. A comprehensive method to develop a checklist to increase safety of intra-hospital transport of critically ill patients. Crit Care. 2015;19(1):214.","journal-title":"Crit Care"},{"year":"2012","author":"Klei WA","key":"ref13","unstructured":"van Klei WA, Hoff RG, van Aarnhem EEHL, Simmermacher RKJ, Regli LPE, Kappen TH et al. Effects of the Introduction of the WHO \u201cSurgical Safety Checklist\u201d on In-Hospital Mortality: A Cohort Study.Annals of Surgery. 2012;255(1)."},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"e048178","DOI":"10.1136\/bmjopen-2020-048178","article-title":"Progression from external pilot to definitive randomised controlled trial: a methodological review of progression criteria reporting","volume":"11","author":"Mellor K","year":"2021","unstructured":"Mellor K, Eddy S, Peckham N, Bond CM, Campbell MJ, Lancaster GA, et al. Progression from external pilot to definitive randomised controlled trial: a methodological review of progression criteria reporting. BMJ open. 2021;11(6):e048178.","journal-title":"BMJ open"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-10-67","article-title":"What is a pilot or feasibility study? A review of current practice and editorial policy","volume":"10","author":"Arain M","year":"2010","unstructured":"Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10(1):1\u20137.","journal-title":"BMC Med Res Methodol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2016.07.032","article-title":"Behavioral Risk Assessment for Infectious Diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users","volume":"168","author":"Dunn KE","year":"2016","unstructured":"Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral Risk Assessment for Infectious Diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug Alcohol Depend. 2016;168:69\u201375.","journal-title":"Drug Alcohol Depend"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.02.019","article-title":"Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations","volume":"162","author":"Smith LR","year":"2016","unstructured":"Smith LR, Earnshaw VA, Copenhaver MM, Cunningham CO. Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations. Drug Alcohol Depend. 2016;162:34\u201343.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1360-0443.1993.tb02058.x","article-title":"Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users","volume":"88","author":"Latkin CA","year":"1993","unstructured":"Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993;88(4):517\u201326.","journal-title":"Addiction"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"e6198","DOI":"10.2196\/resprot.6198","article-title":"Mobile application to promote adherence to oral chemotherapy and symptom management: a protocol for design and development","volume":"6","author":"Fishbein JN","year":"2017","unstructured":"Fishbein JN, Nisotel LE, MacDonald JJ, Pensak NA, Jacobs JM, Flanagan C, et al. Mobile application to promote adherence to oral chemotherapy and symptom management: a protocol for design and development. JMIR Res protocols. 2017;6(4):e6198.","journal-title":"JMIR Res protocols"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3578-y","article-title":"Progression criteria in trials with an internal pilot: an audit of publicly funded randomised controlled trials","volume":"20","author":"Herbert E","year":"2019","unstructured":"Herbert E, Julious SA, Goodacre S. Progression criteria in trials with an internal pilot: an audit of publicly funded randomised controlled trials. Trials. 2019;20(1):1\u20139.","journal-title":"Trials"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40814-021-00770-x","article-title":"Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back!","volume":"7","author":"Lewis M","year":"2021","unstructured":"Lewis M, Bromley K, Sutton CJ, McCray G, Myers HL, Lancaster GA. Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back! Pilot and feasibility studies. 2021;7(1):1\u201314.","journal-title":"Pilot and feasibility studies"},{"year":"2019","author":"Eaton E","key":"ref22","unstructured":"Eaton E, Westfall A, Mathews R. Interdisciplinary intervention for hospitalized PWID may increase MAT use. Conference on Retroviruses and Opportunistic Infections; Seattle, WA2019."},{"author":"Am IR","key":"ref23","unstructured":"Am IR. Rural Health Information Hub; 2022 [Tool]. Available from: https:\/\/www.ruralhealthinfo.org\/am-i-rural."},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40814-021-00770-x","article-title":"Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back!","volume":"7","author":"Lewis M","year":"2021","unstructured":"Lewis M, Bromley K, Sutton CJ, McCray G, Myers HL, Lancaster GA. Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back! Pilot and Feasibility Studies. 2021;7(1):40.","journal-title":"Pilot and Feasibility Studies"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/tmj.2016.0100","article-title":"Beta testing a novel smartphone application to improve medication adherence","volume":"23","author":"Sarzynski E","year":"2017","unstructured":"Sarzynski E, Decker B, Thul A, Weismantel D, Melaragni R, Cholakis E, et al. Beta testing a novel smartphone application to improve medication adherence. Telemedicine and e-Health. 2017;23(4):339\u201348.","journal-title":"Telemedicine and e-Health"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2546488\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2546488\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T18:21:01Z","timestamp":1686162061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2546488\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":25,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2546488\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,6,7]]},"subtype":"preprint"}}